Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion
Keeffe, E.B.; Harper, J.M.; LeMay, A.; Sherrin, T.P.; Siepler, J.K.
Hospital Formulary 26 Suppl D: 13-19
1991
ISSN/ISBN: 0098-6909 PMID: 10136560 Document Number: 370802
Document emailed within 1 workday
Related Documents
DiPiro, J.T.; Steele, J.C. 1987: Rational formulary selection of antimicrobials American Journal of Hospital Pharmacy 44(1): 74Weiss, G.Garfinkel. 2004: Big practice problem: what our experts would do. Roundtable discussion Medical Economics 81(24): 38-42
Fine, D.J.; Guild, R.T.; Kleinmann, K.; Kupersmith, J. 1984: P & T Committee roundtable discussion: Eastern region Pt. II Hospital Formulary 19(7): 561
Fine, D.J.; Guild, R.T.; Kleinmann, K.; Kupersmith, J. 1984: P & T Committee roundtable discussion: Eastern region. Part I Hospital Formulary 19(6): 469-72 475-6
Monheit, G.; Kestemont, P.; Sundaram, H. 2012: Hyaluronic acid fillers on the horizon: roundtable discussion Journal of Drugs in Dermatology: Jdd 11(8): S26
Rao, G.; Davis, R.H.; Peura, D.A.; Wright, W.L. 2005: Heartburn: issues in patient management. A roundtable discussion Journal of Family Practice 54(6): S1-S6
McQuone, M.; Salberg, D.; Weintraub, M. 1983: P & T Committee roundtable discussion: Great Lakes region, Part I Hospital Formulary 18(12): 1116-1121
Penna, P.; Cox, E.; Joseph, T.; Lehman, L.; Morrow, T.; Richter, A.; Sowers, J.; Tepper, D. 2000: Roundtable discussion: Part II--Development of a pharmacoeconomic model in hypertension Managed care interface Suppl C: 17-23
Oftedahl, G.; Marshall, M. 2010: The future of personal health records: a summary of a roundtable discussion Minnesota Medicine 93(7): 50-52
Bonick, M.; Molden, M.; Oostra, R. 2009: Outpatient outlook. CEO roundtable discussion examines how far the ambulatory market has come and where it's going Modern Healthcare 39(47): 26-29
Goodman, C. 1998: Roundtable discussion. Investigational exclusion, clinical trials, and cancer Oncology 12(11a): 37-49
Rybak, M.J.; Allen, R.; Arnow, P.; Craven, P.C.; Freeman, R.; Grüneberg, R.N.; Korin, J.; Nightingale, C.H.; Rubinstein, E.; Schaison, G.S. 1993: Roundtable discussion. Maximizing potential cost benefits of teicoplanin through appropriate usage Hospital Formulary 28 Suppl. 1: 62-68
Eichenfield, L.F.; Fried, R.G.; Taylor, S.C.; Paller, A.S.; Theos, A. 2005: Acne and your pediatric patient: a roundtable discussion of treatment modalities and other factors Cutis 76(5 Suppl): 5-24
Zurawin, R.K.; Sanfilippo, J.; Bacon, J.; Templeman, C. 2002: Advanced surgical techniques in the pediatric and adolescent patient. Roundtable discussion Journal of Pediatric and Adolescent Gynecology 15(3): 183-191
Sanders, P.S.; Bland, R.J.; Board, R.; Lincoln, E.; Smith, A.J. 1987: Confronting professional liability: a roundtable discussion of medical risk management Minnesota Medicine 70(3): 142-148
Lilja, J. 1979: Drug product selection by formulary committees in Sweden American Journal of Hospital Pharmacy 36(8): 1042 1044
Butler, R.N.; Collins, K.S.; Meier, D.S.; Muller, C.T.; Pinn, V.W. 1995: Older women's health: clinical care in the postmenopausal years. A roundtable discussion part 2 Geriatrics 50(6): 33-6 39-41
Czuczman, M.S.; Leonard, J.P.; Williams, M.E. 2010: Clinical roundtable monograph: Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussion Clinical Advances in Hematology and Oncology: H&o 8(4 Suppl. 8): 1-14; Quiz 2p Following Page 14
Wang, Y.R.; Pauly, M.V. 2005: Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors Managed Care Interface 18(8): 39-45
Meyer zu Schwabedissen, O.A. 1978: Discussion to the 2nd main topic "Rational diagnosis and therapy" Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1978(84): 267-268